可視化

クラスタサイズ(論文数)

28

クラスタの分野

2700:Medicine
(比率: 54.2 %)

発行年ごと論文数

著者正規化top50

著者正規化top50の共著関係

タイトル語top50

タイトル語top50の共起

ジャーナル一覧

ジャーナル分野比率


論文リスト

DOI タイトル 著者 ジャーナル 発行年 科研費成果論文
10.1001/jamaoncol.2018.4475 Alpelisib Plus Fulvestrant In Pik3Ca-Altered And Pik3Ca-Wild-Type Estrogen Receptor<U+2013>Positive Advanced Breast Cancer Juric, Dejan; Janku, Filip; Rodon, Jordi; Burris, Howard A.; Mayer, Ingrid A.; Schuler, Martin; Seggewiss-Bernhardt, Ruth; Gil-Martin, Marta; Middleton, Mark R.; Baselga, Jose; Bootle, Douglas; Demanse, David; Blumenstein, Lars; Schumacher, Karl; Huang, Alan; Quadt, Cornelia; Rugo, Hope S. Jama Oncology 2019 NA
10.1001/jamaoncol.2019.4782 Sledge, George W.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena; Masuda, Norikazu; Kaufman, Peter A.; Koh, Han; Grischke, Eva-Maria; Conte, Pierfranco; Lu, Yi; Barriga, Susana; Hurt, Karla; Frenzel, Martin; Johnston, Stephen; Llombart-Cussac, Antonio Jama Oncology 2020 NA
10.1002/ijc.32020 Molecular Mechanisms Of Resistance To Cdk4/6 Inhibitors In Breast Cancer: A Review International Journal Of Cancer 2019 NA
10.1007/s10549-018-05125-4 Palbociclib Plus Letrozole As First-Line Therapy In Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer With Extended Follow-Up Rugo, H. S.; Finn, R. S.; Dieras, V.; Ettl, J.; Lipatov, O.; Joy, A. A.; Harbeck, N.; Castrellon, A.; Iyer, S.; Lu, D. R.; Mori, A.; Gauthier, E. R.; Bartlett, C. Huang; Gelmon, K. A.; Slamon, D. J. Breast Cancer Research And Treatment 2019 NA
10.1016/j.ccell.2018.08.008 The Genomic Landscape Of Endocrine-Resistant Advanced Breast Cancers Razavi, Pedram; Chang, Matthew T.; Xu, Guotai; Bandlamudi, Chaitanya; Ross, Dara S.; Vasan, Neil; Cai, Yanyan; Bielski, Craig M.; Donoghue, Mark T.A.; Jonsson, Philip; Penson, Alexander; Shen, Ronglai; Pareja, Fresia; Kundra, Ritika; Middha, Sumit; Cheng, Michael L.; Zehir, Ahmet; Kandoth, Cyriac; Patel, Ruchi; Huberman, Kety; Smyth, Lillian M.; Jhaveri, Komal; Modi, Shanu; Traina, Tiffany A.; Dang, Chau; Zhang, Wen; Weigelt, Britta; Li, Bob T.; Ladanyi, Marc; Hyman, David M.; Schultz, Nikolaus; Robson, Mark E.; Hudis, Clifford; Brogi, Edi; Viale, Agnes; Norton, Larry; Dickler, Maura N.; Berger, Michael F.; Iacobuzio-Donahue, Christine A.; Chandarlapaty, Sarat; Scaltriti, Maurizio; Reis-Filho, Jorge S.; Solit, David B.; Taylor, Barry S.; Baselga, Jose Cancer Cell 2018 NA
10.1016/j.ccell.2018.11.006 Loss Of The Fat1 Tumor Suppressor Promotes Resistance To Cdk4/6 Inhibitors Via The Hippo Pathway Li, Zhiqiang; Razavi, Pedram; Li, Qing; Toy, Weiyi; Liu, Bo; Ping, Christina; Hsieh, Wilson; Sanchez-Vega, Francisco; Brown, David N.; Da Cruz Paula, Arnaud F.; Morris, Luc; Selenica, Pier; Eichenberger, Emily; Shen, Ronglai; Schultz, Nikolaus; Rosen, Neal; Scaltriti, Maurizio; Brogi, Edi; Baselga, Jose; Reis-Filho, Jorge S.; Chandarlapaty, Sarat, 0000-0003-4532-8053 Cancer Cell 2018 NA
10.1016/j.chembiol.2019.05.005 Multiomics Profiling Establishes The Polypharmacology Of Fda-Approved Cdk4/6 Inhibitors And The Potential For Differential Clinical Activity Hafner, Marc, 0000-0003-1337-7598; Mills, Caitlin E.; Subramanian, Kartik; Chen, Chen; Chung, Mirra; Boswell, Sarah A.; Everley, Robert A.; Liu, Changchang; Walmsley, Charlotte S.; Juric, Dejan; Sorger, Peter K. Cell Chemical Biology 2019 NA
10.1016/s1470-2045(18)30292-4 Ribociclib Plus Endocrine Therapy For Premenopausal Women With Hormone-Receptor-Positive, Advanced Breast Cancer (Monaleesa-7): A Randomised Phase 3 Trial Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Villanueva Vazquez, Rafael; Jung, Kyung Hae; Babu, K Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan; Germa, Caroline; Hirawat, Samit; Lu, Yen-Shen The Lancet Oncology 2018 NA
10.1016/s1470-2045(19)30420-6 Endocrine Treatment Versus Chemotherapy In Postmenopausal Women With Hormone Receptor-Positive, Her2-Negative, Metastatic Breast Cancer: A Systematic Review And Network Meta-Analysis Giuliano, Mario; Schettini, Francesco; Rognoni, Carla; Milani, Manuela; Jerusalem, Guy; Bachelot, Thomas; De Laurentiis, Michelino; Thomas, Guglielmo; De Placido, Pietro; Arpino, Grazia; De Placido, Sabino; Cristofanilli, Massimo; Giordano, Antonio; Puglisi, Fabio; Pistilli, Barbara; Prat, Aleix; Del Mastro, Lucia; Venturini, Sergio; Generali, Daniele The Lancet Oncology 2019 NA
10.1016/s1470-2045(19)30804-6 Cdk4/6 Inhibitor Treatment For Patients With Hormone Receptor-Positive, Her2-Negative, Advanced Or Metastatic Breast Cancer: A Us Food And Drug Administration Pooled Analysis Gao, Jennifer J; Cheng, Joyce; Bloomquist, Erik; Sanchez, Jacquelyn; Wedam, Suparna B; Singh, Harpreet; Amiri-Kordestani, Laleh; Ibrahim, Amna; Sridhara, Rajeshwari; Goldberg, Kirsten B; Theoret, Marc R; Kluetz, Paul G; Blumenthal, Gideon M; Pazdur, Richard; Beaver, Julia A; Prowell, Tatiana M The Lancet Oncology 2020 NA
10.1016/s1470-2045(19)30817-4 Fulvestrant Plus Capivasertib Versus Placebo After Relapse Or Progression On An Aromatase Inhibitor In Metastatic, Oestrogen Receptor-Positive Breast Cancer (Faktion): A Multicentre, Randomised, Controlled, Phase 2 Trial Jones, Robert H; Casbard, Angela; Carucci, Margherita; Cox, Catrin; Butler, Rachel; Alchami, Fouad; Madden, Tracie-Ann; Bale, Catherine; Bezecny, Pavel; Joffe, Johnathan; Moon, Sarah; Twelves, Chris; Venkitaraman, Ramachandran; Waters, Simon; Foxley, Andrew; Howell, Sacha J The Lancet Oncology 2020 NA
10.1038/s41467-019-09068-2 Aberrant Fgfr Signaling Mediates Resistance To Cdk4/6 Inhibitors In Er+ Breast Cancer Nature Communications 2019 NA
10.1038/s41523-018-0097-z Monarch 3 Final Pfs: A Randomized Study Of Abemaciclib As Initial Therapy For Advanced Breast Cancer Johnston, Stephen; Martin, Miguel; Di Leo, Angelo; Im, Seock-Ah; Awada, Ahmad; Forrester, Tammy; Frenzel, Martin; Hardebeck, Molly C.; Cox, Joanne; Barriga, Susana; Toi, Masakazu; Iwata, Hiroji; Goetz, Matthew P. Npj Breast Cancer 2019 NA
10.1038/s41588-018-0287-5 Acquired Her2 Mutations In Er+ Metastatic Breast Cancer Confer Resistance To Estrogen Receptor<U+2013>Directed Therapies Nayar, Utthara; Cohen, Ofir; Kapstad, Christian; Cuoco, Michael S.; Waks, Adrienne G., 0000-0001-5649-7229; Wander, Seth A.; Painter, Corrie; Freeman, Samuel; Persky, Nicole S.; Marini, Lori; Helvie, Karla; Oliver, Nelly; Rozenblatt-Rosen, Orit; Ma, Cynthia X.; Regev, Aviv; Winer, Eric P.; Lin, Nancy U.; Wagle, Nikhil, 0000-0003-3332-9438 Nature Genetics 2018 NA
10.1056/nejmoa1810527 Overall Survival With Palbociclib And Fulvestrant In Advanced Breast Cancer Turner, Nicholas C.; Slamon, Dennis J.; Ro, Jungsil; Bondarenko, Igor; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; Demichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Andre, Fabrice; Puyana Theall, Kathy; Huang, Xin; Giorgetti, Carla; Huang Bartlett, Cynthia; Cristofanilli, Massimo New England Journal Of Medicine 2018 NA
10.1056/nejmoa1813904 Alpelisib For Pik3Ca-Mutated, Hormone Receptor<U+2013>Positive Advanced Breast Cancer Andre, Fabrice; Ciruelos, Eva; Rubovszky, Gabor; Campone, Mario; Loibl, Sibylle; Rugo, Hope S.; Iwata, Hiroji; Conte, Pierfranco; Mayer, Ingrid A.; Kaufman, Bella; Yamashita, Toshinari; Lu, Yen-Shen; Inoue, Kenichi; Takahashi, Masato; Papai, Zsuzsanna; Longin, Anne-Sophie; Mills, David; Wilke, Celine; Hirawat, Samit; Juric, Dejan New England Journal Of Medicine 2019 NA
10.1056/nejmoa1903765 Overall Survival With Ribociclib Plus Endocrine Therapy In Breast Cancer Im, Seock-Ah; Lu, Yen-Shen; Bardia, Aditya; Harbeck, Nadia; Colleoni, Marco; Franke, Fabio; Chow, Louis; Sohn, Joohyuk; Lee, Keun-Seok; Campos-Gomez, Saul; Villanueva-Vazquez, Rafael; Jung, Kyung-Hae; Chakravartty, Arunava; Hughes, Gareth; Gounaris, Ioannis; Rodriguez-Lorenc, Karen; Taran, Tetiana; Hurvitz, Sara; Tripathy, Debu New England Journal Of Medicine 2019 NA
10.1056/nejmoa1911149 Overall Survival With Ribociclib Plus Fulvestrant In Advanced Breast Cancer Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia V.; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De La Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Sondhi, Manu; Wang, Yingbo; Chakravartty, Arunava; Rodriguez-Lorenc, Karen; Taran, Tetiana; Jerusalem, Guy New England Journal Of Medicine 2020 NA
10.1093/annonc/mdy155 Updated Results From Monaleesa-2, A Phase Iii Trial Of First-Line Ribociclib Plus Letrozole Versus Placebo Plus Letrozole In Hormone Receptor-Positive, Her2-Negative Advanced Breast Cancer Annals Of Oncology 2018 NA
10.1126/science.aaw9032 Vasan, Neil, 0000-0003-1779-484X; Razavi, Pedram, 0000-0003-4236-0576; Johnson, Jared L., 0000-0003-1802-6527; Shao, Hong; Shah, Hardik, 0000-0001-7967-3811; Antoine, Alesia, 0000-0003-4587-322X; Ladewig, Erik, 0000-0002-6661-1803; Gorelick, Alexander, 0000-0001-6736-8246; Lin, Ting-Yu, 0000-0002-8335-364X; Toska, Eneda, 0000-0002-8974-9792; Xu, Guotai, 0000-0001-5265-3407; Kazmi, Abiha; Chang, Matthew T.; Taylor, Barry S., 0000-0002-3355-9471; Dickler, Maura N.; Jhaveri, Komal; Chandarlapaty, Sarat, 0000-0003-4532-8053; Rabadan, Raul, 0000-0001-7946-9255; Reznik, Ed, 0000-0002-6511-5947; Smith, Melissa L., 0000-0001-7151-3207; Sebra, Robert; Schimmoller, Frauke; Wilson, Timothy R.; Friedman, Lori S., 0000-0001-9127-9892; Cantley, Lewis C., 0000-0002-1298-7653; Scaltriti, Maurizio, 0000-0002-5522-1447; Baselga, Jose, 0000-0003-1361-4063 Science 2019 NA
10.1158/1078-0432.ccr-19-0751 Biomarker Analyses Of Response To Cyclin-Dependent Kinase 4/6 Inhibition And Endocrine Therapy In Women With Treatment-Naive Metastatic Breast Cancer Finn, Richard S.; Liu, Yuan; Zhu, Zhou; Martin, Miguel, 0000-0001-9237-3231; Rugo, Hope S.; Dieras, Veronique; Im, Seock-Ah, 0000-0002-5396-6533; Gelmon, Karen A.; Harbeck, Nadia, 0000-0002-9744-7372; Lu, Dongrui R.; Gauthier, Eric; Huang Bartlett, Cynthia; Slamon, Dennis J. Clinical Cancer Research 2019 NA
10.1158/2159-8290.cd-18-0264 The Genetic Landscape And Clonal Evolution Of Breast Cancer Resistance To Palbociclib Plus Fulvestrant In The Paloma-3 Trial O’Leary, Ben; Cutts, Rosalind J.; Liu, Yuan; Hrebien, Sarah; Huang, Xin; Fenwick, Kerry; Andre, Fabrice; Loibl, Sibylle; Loi, Sherene, 0000-0001-6137-9171; Garcia-Murillas, Isaac, 0000-0001-8183-7969; Cristofanilli, Massimo; Huang Bartlett, Cynthia; Turner, Nicholas C. Cancer Discovery 2018 NA
10.1158/2159-8290.cd-18-0830 Costa, Carlotta; Wang, Ye; Ly, Amy; Hosono, Yasuyuki; Murchie, Ellen; Walmsley, Charlotte S.; Huynh, Tiffany; Healy, Christopher, 0000-0001-5916-5115; Peterson, Rachel; Yanase, Shogo; Jakubik, Charles T.; Henderson, Laura E.; Damon, Leah J., 0000-0002-0863-0328; Timonina, Daria; Sanidas, Ioannis; Pinto, Christopher J.; Mino-Kenudson, Mari, 0000-0002-9092-2265; Stone, James R.; Dyson, Nicholas J.; Ellisen, Leif W.; Bardia, Aditya; Ebi, Hiromichi, 0000-0003-3155-7576; Benes, Cyril H., 0000-0002-8751-9707; Engelman, Jeffrey A.; Juric, Dejan Cancer Discovery 2019 TRUE
10.1200/jco.18.00925 Cyclin E1 Expression And Palbociclib Efficacy In Previously Treated Hormone Receptor<U+2013>Positive Metastatic Breast Cancer Turner, Nicholas C.; Liu, Yuan; Zhu, Zhou; Loi, Sherene; Colleoni, Marco; Loibl, Sibylle; Demichele, Angela; Harbeck, Nadia; Andre, Fabrice; Bayar, Mohamed Amine; Michiels, Stefan; Zhang, Zhe; Giorgetti, Carla; Arnedos, Monica; Huang Bartlett, Cynthia; Cristofanilli, Massimo Journal Of Clinical Oncology 2019 NA
10.1200/jco.19.00368 Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy For Metastatic Triple-Negative Breast Cancer: The Pakt Trial Schmid, Peter; Abraham, Jacinta; Chan, Stephen; Wheatley, Duncan; Brunt, Adrian Murray; Nemsadze, Gia; Baird, Richard D.; Park, Yeon Hee; Hall, Peter S.; Perren, Timothy; Stein, Robert C.; Mangel, Laszlo; Ferrero, Jean-Marc; Phillips, Melissa; Conibear, John; Cortes, Javier; Foxley, Andrew; De Bruin, Elza C.; Mcewen, Robert; Stetson, Daniel; Dougherty, Brian; Sarker, Shah-Jalal; Prendergast, Aaron; Mclaughlin-Callan, Max; Burgess, Matthew; Lawrence, Cheryl; Cartwright, Hayley; Mousa, Kelly; Turner, Nicholas C. Journal Of Clinical Oncology 2020 NA
10.1200/jco.2018.78.9909 Phase Iii Randomized Study Of Ribociclib And Fulvestrant In Hormone Receptor<U+2013>Positive, Human Epidermal Growth Factor Receptor 2<U+2013>Negative Advanced Breast Cancer: Monaleesa-3 Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De La Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Vidam, Gena; Wang, Yingbo; Rodriguez Lorenc, Karen; Miller, Michelle; Taran, Tetiana; Jerusalem, Guy Journal Of Clinical Oncology 2018 NA
10.1530/erc-18-0317 Overcoming Cdk4/6 Inhibitor Resistance In Er-Positive Breast Cancer Portman, Neil; Alexandrou, Sarah; Carson, Emma; Wang, Shudong; Lim, Elgene; Caldon, C Elizabeth Endocrine-Related Cancer 2019 NA
10.3389/fonc.2019.00666 Mechanisms Of Resistance To Cdk4/6 Inhibitors: Potential Implications And Biomarkers For Clinical Practice Mccartney, Amelia; Migliaccio, Ilenia; Bonechi, Martina; Biagioni, Chiara; Romagnoli, Dario; De Luca, Francesca; Galardi, Francesca; Risi, Emanuela; De Santo, Irene; Benelli, Matteo; Malorni, Luca; Di Leo, Angelo Frontiers In Oncology 2019 NA